Executive Summary
Background
-
Establishment of the Biologics CDMO Sector
-
Maturing and Preliminary Shakedown of the Biologics
-
Imaging, Diagnostic, and Therapeutic Applications
-
Antibodies Increasingly Important in Animal Health
-
From Mouse to Human mAbs
-
Advances in High-Throughput mAb Discovery Technologies
-
Leveraging Digital Technologies for mAb Design
-
Addressing Patient Access Issues
-
The Role of mAbs in Fighting COVID-19
-
Next-Generation Antibodies Gaining Traction
-
In Vivo Antibody Production
-
Continuing Investment
-
Supply Chain and Talent Acquisition Remain Areas of Concern
-
Looking to the Future
Section I:
BioPharma Market Overview
-
Study Methodology – About This Report
-
Key Market Drivers
-
Market Size – Projections About the Overall Global Biopharmaceutical Market
-
Market Segmentation by Therapeutic Area
Section II:
Biopharma Production and Technologies
-
Introduction
-
Expression Systems
-
Mammalian Expression Systems
-
Microbial Expression Systems
-
Other – Plant-and Insect-Based Systems
-
◦
Plant-Based Expression
-
◦
Insect Based Expression
-
Potentially Disruptive Expression and Production Technologies
-
Expression System Market Size
-
Advances in Biologics Processing
-
Technologies and Advances in Upstream Processing
-
Reactors-Supplier Landscape and Stainless Steel vs. Single Use
-
Technologies and Advances in Downstream Processing
-
Technologies and Advances in Analytical Techniques
-
The Promise of Continuous Manufacturing
-
Electronic Systems and Digital Advances
Section III:
Biopharma Market by Product Type
-
Recombinant Proteins Including Antibodies and Antibody–Drug Conjugates (ADCs)
-
◦
Monoclonal Antibodies (mAbs)
-
◦
Antibody–Drug Conjugates (ADCs)
-
Plasma Proteins – Key Products and Technologies
-
Hormones and Growth Factors
-
◦
Hormones
-
◦
Growth Factors
-
Vaccines
-
◦
Global Market
-
◦
Recombinant Vaccines
-
Biosimilars
-
Next-Generation Therapies
-
◦
Next-Generation Antibody Products
-
◦
Viral Vector Products
-
◦
Gene and Gene-Modified Cell Therapies
-
◦
Cell Therapies
Section IV:
Biopharma Market by Development Stage
Section V:
Biopharma Contract Development and Manufacturing Market
-
Market Definition
-
Overall Market Size and State
-
Services Offered by Biopharmaceutical CDMOs
-
Cell Line and Strain Development and Selection
-
Cell Banking and Characterization
-
Process Development, Optimization, Scale-up, and Technology Transfer
-
cGMP Drug Substance Manufacture
-
Biopharmaceutical CDMO Market Size and Growth
-
Biopharmaceutical CDMO Market Fragmentation and Consolidation
-
Geographic Market Expansion
Section VI:
Capacity Expansion and Investment
-
Regional Analysis
-
Capacity Cycles
-
Recent CDMO Capacity Expansions
Section VII:
Barriers to Entry and Hurdles to Growth
-
Global Talent Shortage
-
Supply Chain Disruption
Section VIII:
Biopharma Contract Manufacturing Pricing Study
-
Study Methodology
-
Pricing Metrics
Section IX:
Biologics CDMO Company Overview and Profiles
Appendix I:
References
.svg)
